Andrew Heller

507 total citations
9 papers, 355 citations indexed

About

Andrew Heller is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Andrew Heller has authored 9 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 5 papers in Pediatrics, Perinatology and Child Health and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Andrew Heller's work include Epilepsy research and treatment (5 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Neuroscience and Neuropharmacology Research (3 papers). Andrew Heller is often cited by papers focused on Epilepsy research and treatment (5 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Neuroscience and Neuropharmacology Research (3 papers). Andrew Heller collaborates with scholars based in United Kingdom and United States. Andrew Heller's co-authors include E. H. Reynolds, Robert Elwes, Howard Ring, Pamela Crawford, Paul Chesterman, David Chadwick, A. L. Johnson, Ibrahim Farr, A. L. Johnson and William Marshall and has published in prestigious journals such as American Journal of Psychiatry, Journal of Neurology Neurosurgery & Psychiatry and Epilepsia.

In The Last Decade

Andrew Heller

8 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Heller United Kingdom 7 304 270 128 46 25 9 355
J Blacklaw United Kingdom 11 385 1.3× 344 1.3× 110 0.9× 61 1.3× 25 1.0× 11 420
Mogens Dam Denmark 4 289 1.0× 233 0.9× 148 1.2× 31 0.7× 10 0.4× 7 346
SD Shorvon United Kingdom 3 436 1.4× 384 1.4× 142 1.1× 57 1.2× 28 1.1× 3 481
Blaise Bourgeois United States 9 268 0.9× 194 0.7× 99 0.8× 26 0.6× 14 0.6× 15 312
Manuel Nieto Barrera Spain 5 297 1.0× 253 0.9× 101 0.8× 31 0.7× 22 0.9× 12 337
Iiris Nousiainen Finland 9 338 1.1× 209 0.8× 170 1.3× 29 0.6× 7 0.3× 10 471
B. Tonnby Sweden 10 305 1.0× 265 1.0× 89 0.7× 20 0.4× 10 0.4× 13 480
E.L. Mullens United Kingdom 4 450 1.5× 406 1.5× 131 1.0× 53 1.2× 39 1.6× 5 532
A. Schellekens Netherlands 7 300 1.0× 246 0.9× 93 0.7× 28 0.6× 10 0.4× 7 354
Matthias Noack‐Rink Germany 5 377 1.2× 272 1.0× 196 1.5× 40 0.9× 17 0.7× 6 497

Countries citing papers authored by Andrew Heller

Since Specialization
Citations

This map shows the geographic impact of Andrew Heller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Heller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Heller more than expected).

Fields of papers citing papers by Andrew Heller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Heller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Heller. The network helps show where Andrew Heller may publish in the future.

Co-authorship network of co-authors of Andrew Heller

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Heller. A scholar is included among the top collaborators of Andrew Heller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Heller. Andrew Heller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Heller, Andrew, Paul Chesterman, Robert Elwes, et al.. (1995). Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial.. Journal of Neurology Neurosurgery & Psychiatry. 58(1). 44–50. 192 indexed citations
3.
Reynolds, E. H., Howard Ring, Ibrahim Farr, Andrew Heller, & Robert Elwes. (1991). Open, Double‐Blind and Long‐Term Study of Vigabatrin in Chronic Epilepsy. Epilepsia. 32(4). 530–538. 43 indexed citations
4.
Ring, Howard, Andrew Heller, William Marshall, A. L. Johnson, & E. H. Reynolds. (1991). Plasma uric acid in patients receiving anticonvulsant monotherapy. Epilepsy Research. 8(3). 241–244. 28 indexed citations
5.
Ring, Howard, Andrew Heller, Ibrahim Farr, & E. H. Reynolds. (1990). Vigabatrin: rational treatment for chronic epilepsy.. Journal of Neurology Neurosurgery & Psychiatry. 53(12). 1051–1055. 41 indexed citations
6.
Heller, Andrew, Howard Ring, & E. H. Reynolds. (1988). Factors relating to dramatic response to clobazam therapy in refractory epilepsy. Epilepsy Research. 2(4). 276–280. 25 indexed citations
7.
Reynolds, E. H., Howard Ring, & Andrew Heller. (1988). A controlled trial of gamma-vinyl-GABA (vigabatrin) in drug-resistant epilepsy.. PubMed. 61. 33–33. 11 indexed citations
8.
Heller, Andrew, et al.. (1971). Effectiveness of Antidepressant Drugs: A Triple-Blind Study Comparing Imipramine, Desipramine, and Placebo. American Journal of Psychiatry. 127(8). 1092–1095. 13 indexed citations
9.
Heller, Andrew, et al.. (1956). [Blood sugar reducing sulfonamides].. PubMed. 86(24). 699–705. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026